Seeking Alpha

Merck to build $1B Delaware plant to ensure domestic supply of Keytruda

Merck (NYSE:MRK) has broken ground on a $1 billion facility in Wilmington, Delaware, becoming the latest pharmaceutical company to boost domestic investment as industry-targeted tariffs loom. This 470 ...
Seeking Alpha

Merck Breaks Ground on New $1 Billion Biologics Center of Excellence in Wilmington, Delaware

Merck (MRK) Wilmington Biotech will serve as a launch and commercial production facility and the future U.S. home for KEYTRUDA A cornerstone of Merck’s continued commitment to investing in American ...
The Business Journals

Merck to build $1B biologics center in Wilmington

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Merck estimates the project will ...
The Daily Gazette

Merck plans to move manufacturing of its biggest drug, Keytruda, to a new US factory and lab in Delaware

Merck, the New Jersey-based drug giant, is spending $1 billion on a new Delaware factory to bring production of its best-selling cancer drug Keytruda to the U.S. and speed future drugs to market.